New Episodes and Suicidal Risks in Bipolar and Major Depressive Disorder Patients During Versus Before Long‐Term Treatment With Lithium
Acta Psychiatrica Scandinavica · 2025
DOI: 10.1111/acps.70002 ↗At a glance
Journal article in Acta Psychiatrica Scandinavica, 2025. Written by Maurizio Pompili and 7 co-authors. Institution: Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Centre, Sant'andrea Hospital, Sapienza University of Rome, Rome, It…. Major MEDLINE topics: Bipolar Disorder, Major Depressive Disorder, Suicide, Attempted, Suicidal Ideation. Cited 3 times so far (Crossref); 59 references. The full text is freely available (open access, CC BY 4.0). Funded by: Bruce J. Anderson Foundation, McLean Private Donors Research Fund (to RJB)., Universita degli Studi di Roma La Sapienza.
Abstract (original language)
Objectives
Lithium treatment reduces the risk of recurring episodes in bipolar disorder (BD) and probably also in major depressive disorder (MDD) and has evidence of antisuicidal effects. Study objectives were to test for effects of adding lithium treatment for one year to a year of other treatments on risks of illness recurrence, suicidal ideation, and suicide attempts.
Methods
We compared 296 major mood disorder outpatients for 12 months with treatment that did not include lithium versus 12 months with lithium included. We considered differences in the recurrence of new episodes of illness, new suicidal ideation and suicide attempts, and estimated time to these outcomes with survival analyses.
Results
With lithium treatment included, there were marked reductions in episode recurrences (3.12‐fold), suicidal ideation (4.78‐fold), and suicide attempts (6.54‐fold) in both BD and MDD patients, with corresponding delays to these outcomes.
Conclusions
Adding lithium treatment was strongly associated with reduced risk and delay of clinical recurrence, suicidal ideation and suicide attempts in both BD and MDD outpatients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Centre, Sant'andrea Hospital, Sapienza University of Rome, Rome, Italy.
- International Consortium for Bipolar & Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, Massachusetts, USA.
- Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine/Grady Health Systems, Atlanta, Georgia, USA.
- Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
ORCID profiles: Maurizio Pompili, Ross J Baldessarini
Funding
- Bruce J. Anderson Foundation
- McLean Private Donors Research Fund (to RJB).
- Universita degli Studi di Roma La Sapienza
Cite
APA
Pompili, M., Berardelli, I., Sarubbi, S., Rogante, E., Cifrodelli, M., Erbuto, D., Lamis, D. A., & Baldessarini, R. J. (2025). New Episodes and Suicidal Risks in Bipolar and Major Depressive Disorder Patients During Versus Before Long‐Term Treatment With Lithium. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.70002
Vancouver
Pompili M, Berardelli I, Sarubbi S, Rogante E, Cifrodelli M, Erbuto D, et al. New Episodes and Suicidal Risks in Bipolar and Major Depressive Disorder Patients During Versus Before Long‐Term Treatment With Lithium. Acta Psychiatrica Scandinavica. 2025. doi:10.1111/acps.70002
BibTeX
@article{Pompili2025,
author = {Pompili, Maurizio and Berardelli, Isabella and Sarubbi, Salvatore and Rogante, Elena and Cifrodelli, Mariarosaria and Erbuto, Denise and Lamis, Dorian A and Baldessarini, Ross J},
title = {New Episodes and Suicidal Risks in Bipolar and Major Depressive Disorder Patients During Versus Before Long‐Term Treatment With Lithium},
journal = {Acta Psychiatrica Scandinavica},
year = {2025},
doi = {10.1111/acps.70002}
}
EUVIMED